Journal article
Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice.
-
Krawczyk K
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Xue S
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Buchmann P
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Charpin-El-Hamri G
Département Génie Biologique, Institut Universitaire de Technologie Lyon 1, F-69622 Villeurbanne Cedex, France.
-
Saxena P
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Hussherr MD
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Shao J
Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, People's Republic of China.
-
Ye H
Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, People's Republic of China.
-
Xie M
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland.
-
Fussenegger M
Department of Biosystems Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland. fussenegger@bsse.ethz.ch.
Show more…
Published in:
- Science (New York, N.Y.). - 2020
English
Sophisticated devices for remote-controlled medical interventions require an electrogenetic interface that uses digital electronic input to directly program cellular behavior. We present a cofactor-free bioelectronic interface that directly links wireless-powered electrical stimulation of human cells to either synthetic promoter-driven transgene expression or rapid secretion of constitutively expressed protein therapeutics from vesicular stores. Electrogenetic control was achieved by coupling ectopic expression of the L-type voltage-gated channel CaV1.2 and the inwardly rectifying potassium channel Kir2.1 to the desired output through endogenous calcium signaling. Focusing on type 1 diabetes, we engineered electrosensitive human β cells (Electroβ cells). Wireless electrical stimulation of Electroβ cells inside a custom-built bioelectronic device provided real-time control of vesicular insulin release; insulin levels peaked within 10 minutes. When subcutaneously implanted, this electrotriggered vesicular release system restored normoglycemia in type 1 diabetic mice.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/295182
Statistics
Document views: 8
File downloads: